cDNA microarray study to identify expression changes relevant for apoptosis in K562 cells co-treated with amifostine and imatinib

被引:12
|
作者
Bianchini, Michele
Martinelli, Giovanni
Renzulli, Matteo
Cid, Marcela Gonzalez
Larripa, Irene
机构
[1] Acad Natl Med, Dept Genet, Inst Invest Hematol Mariano R Castex, RA-1425 Buenos Aires, DF, Argentina
[2] Univ Bologna, Inst Hematol & Med Oncol L EA Seragnoli, Bologna, Italy
关键词
microarray; apoptosis; amifostine; imatinib; BTF;
D O I
10.1007/s00280-006-0276-8
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose Chronic myeloid leukemia is a clonal myeloproliferative disorder characterized by the presence of the fusion gene BCR/ABL. We had previously demonstrated an increased proapoptotic effect of imatinib (STI571) in combination with amifostine (AMI) in K562 cell line. In this study, we used genomic scale gene expression profiling to monitor changes at transcriptional level in K562 cells during the treatment with AMI + STI571. Materials and methods cRNA from Control and treated K562 cells were mixed in equal amounts and incubated with a microarray slide for hybridization. RNA from six independent paired experiments was subjected to transcriptional profiling. With the aim to automate the process of biological theme determination, selected genes were further analyzed by EASE. Validation of the expression was carried out by quantitative real-time PCR and western blotting. Results As expected, a small percentage of genes accounts for the effects of the combined drug treatment. We identified 61 sequences corresponding to known genes; 17 of the 61 genes were up regulated, such as RHO6, PPP2R5E, PPM1E and BTF that appear to reflect favorable events for apoptosis induction. Between down regulated genes, API5, TUBB2 and TLK1 are also of considerable interest. Conclusion We identified a transcriptional repressor of survival genes, known as BTF, which triggers a proapoptotic signal, potentially helpful to overcome the resistance to STI571. This finding could be particularly useful to design novel therapeutic strategies for leukemia patients. This study demonstrates the importance of in vitro testing of a novel drug combination most likely to predict its potential usefulness for in vivo application.
引用
收藏
页码:349 / 360
页数:12
相关论文
共 50 条
  • [1] cDNA microarray study to identify expression changes relevant for apoptosis in K562 cells co-treated with amifostine and imatinib
    Michele Bianchini
    Giovanni Martinelli
    Matteo Renzulli
    Marcela Gonzalez Cid
    Irene Larripa
    Cancer Chemotherapy and Pharmacology, 2007, 59 : 349 - 360
  • [2] EXOSOMES DERIVED FROM K562/G01 CELLS REDUCE APOPTOSIS OF K562 CELLS TREATED WITH IMATINIB
    Huang, Bo
    Feng, Qin
    Li, Jing
    Liu, Jing
    Chen, Xin
    Xu, Mei
    Chen, Min
    Zhang, Bin
    Lin, Jin
    Huang, Feng
    Wang, Zhong
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2014, 36 : 104 - 105
  • [3] Erythropoietin enhances the development of resistance in imatinib treated K562 cells
    Kirschner, K
    Porzig, H
    Baltensperger, K
    EXPERIMENTAL HEMATOLOGY, 2003, 31 (07) : 229 - 230
  • [4] Differential expression and alternative splicing of cell cycle genes in imatinib-treated K562 cells
    Liu, Jing
    Lin, Jin
    Huang, Lin-Feng
    Huang, Bo
    Xu, Yan-Mei
    Li, Jing
    Wang, Yan
    Zhang, Jing
    Yang, Wei-Ming
    Min, Qing-Hua
    Wang, Xiao-Zhong
    TUMOR BIOLOGY, 2015, 36 (10) : 8127 - 8136
  • [5] DIFFERENTIAL EXPRESSION AND ALTERNATIVE SPLICING OF CELL CYCLE GENES IN IMATINIB-TREATED K562 CELLS
    Liu Jing
    Huang Bo
    Chen Xin
    Xu Yanmei
    Chen Ximin
    Wang Xiaozhong
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2014, 36 : 105 - 105
  • [6] Apoptosis Induction of K562 Cells by Lymphocytes: An AFM Study
    Jin, Hua
    Zhao, Hongxia
    Liu, Li
    Jiang, Jinhuan
    Wang, Xiaoping
    Ma, Shuyuan
    Cai, Jiye
    SCANNING, 2013, 35 (01) : 7 - 11
  • [7] Gene expression profiling in apoptotic k562 cells treated by homoharringtonine
    Jin, Wei
    Wu, Jiong
    Zhuang, Zhigang
    Li, Junjie
    Fei, Fei
    Di, Genhong
    Chen, Ying
    Yao, Ming
    Shao, Zhimin
    ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 2007, 39 (12) : 982 - 991
  • [8] Alternative splicing of apoptosis-related genes in imatinib-treated K562 cells identified by exon array analysis
    Liu, Jing
    Xiao, Yun
    Xiong, Huo-Mei
    Li, Jing
    Huang, Bo
    Zhang, Hai-Bin
    Feng, Dan-Qin
    Chen, Xi-Min
    Wang, Xiao-Zhong
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2012, 29 (04) : 690 - 698
  • [9] Proteome Changes Induced by Imatinib and Novel Imatinib Derivatives in K562 Human Chronic Myeloid Leukemia Cells
    Arvaniti, Katerina
    Papadioti, Anastasia
    Kinigopoulou, Maria
    Theodorou, Vassiliki
    Skobridis, Konstantinos
    Tsiotis, Georgios
    PROTEOMES, 2014, 2 (03): : 363 - 381
  • [10] Using an exon microarray to identify a global profile of gene expression and alternative splicing in K562 cells exposed to sodium valproate
    Zhang, Xiang-Zhong
    Yin, Ai-Hua
    Zhu, Xiao-Yu
    Ding, Qian
    Wang, Chun-Huai
    Chen, Yun-Xian
    ONCOLOGY REPORTS, 2012, 27 (04) : 1258 - 1265